Merkel cell carcinoma: Diagnosis, management, and outcomes

Plastic and Reconstructive Surgery

Volumn 131, Issue 5, 2013, Pages

  Senchenkov, Alex ^a   Moran, Steven L ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL; CANCER STAGING; HUMAN; MERKEL CELL TUMOR; METHODOLOGY; PATHOLOGY; REVIEW; SENTINEL LYMPH NODE BIOPSY; SKIN TUMOR; TREATMENT OUTCOME;

ANIMALS; CARCINOMA, MERKEL CELL; HUMANS; NEOPLASM STAGING; SENTINEL LYMPH NODE BIOPSY; SKIN NEOPLASMS; TREATMENT OUTCOME;

MLCS; MLOWN;

EID: 84877748122     PISSN: 00321052     EISSN: None     Source Type: Journal    
DOI: 10.1097/PRS.0b013e3182865cf3     Document Type: Article

References (56)

1. Goessling W, McKee PH, Mayer RJ. Merkel cell carcinoma. J Clin Oncol. 2002;20:588-598.
2. Halata Z, Grim M, Bauman KI. Friedrich Sigmund Merkel and his "Merkel cell," morphology, development, and physiology: Review and new results. Anat Rec A Discov Mol Cell Evol Biol. 2003;271:225-239.
3. Hashimoto K. The ultrastructure of the skin of human embryos: X. Merkel tactile cells in the finger and nail. J Anat. 1972;111(Pt 1):99-120.
4. Szeder V, Grim M, Halata Z, Sieber-Blum M. Neural crest origin of mammalian Merkel cells. Dev Biol. 2003; 253:258-263.
5. Toker C. Trabecular carcinoma of the skin. Arch Dermatol. 1972;105:107-110.
6. Tang CK, Toker C. Trabecular carcinoma of the skin: An ultrastructural study. Cancer 1978;42:2311-2321.
7. De Wolff-Peeters C, Marien K, Mebis J, Desmet V. A cutaneous APUDoma or Merkel cell tumor? A morphologically recognizable tumor with a biological and histological malignant aspect in contrast with its clinical behavior. Cancer 1980;46:1810-1816.
8. Hewitt JB, Sherif A, Kerr KM, Stankler L. Merkel cell and squamous cell carcinomas arising in erythema ab igne. Br J Dermatol. 1993;128:591-592.
9. Kuwamoto S. Recent advances in the biology of Merkel cell carcinoma. Hum Pathol. 2011;42:1063-1077.
10. Hodgson NC. Merkel cell carcinoma: Changing incidence trends. J Surg Oncol. 2005;89:1-4.
11. Albores-Saavedra J, Batich K, Chable-Montero F, Sagy N, Schwartz AM, Henson DE. Merkel cell carcinoma demographics, morphology, and survival based on 3870 cases: A population based study. J Cutan Pathol. 2010;37:20-27.
12. Moll R, Löwe A, Laufer J, Franke WW. Cytokeratin 20 in human carcinomas: A new histodiagnostic marker detected by monoclonal antibodies. Am J Pathol. 1992;140:427-447.
13. Agelli M, Clegg LX. Epidemiology of primary Merkel cell carcinoma in the United States. J Am Acad Dermatol. 2003;49:832-841.
14. Miller RW, Rabkin CS. Merkel cell carcinoma and melanoma: Etiological similarities and differences. Cancer Epidemiol Biomarkers Prev. 1999;8:153-158.
15. Van Gele M, Kaghad M, Leonard JH, et al. Mutation analysis of P73 and TP53 in Merkel cell carcinoma. Br J Cancer 2000;82:823-826.
16. Lunder EJ, Stern RS. Merkel-cell carcinomas in patients treated with methoxsalen and ultraviolet A radiation. N Engl J Med. 1998;339:1247-1248.
17. Tsuruta D, Hamada T, Mochida K, Nakagawa K, Kobayashi H, Ishii M. Merkel cell carcinoma, Bowen's disease and chronic occupational arsenic poisoning. Br J Dermatol. 1998;139:291-294.
18. Heath M, Jaimes N, Lemos B, et al. Clinical characteristics of Merkel cell carcinoma at diagnosis in 195 patients: The AEIOU features. J Am Acad Dermatol. 2008;58:375-381.
19. Engels EA, Frisch M, Goedert JJ, Biggar RJ, Miller RW. Merkel cell carcinoma and HIV infection. Lancet 2002;359: 497-498.
20. Penn I, First MR. Merkel's cell carcinoma in organ recipients: Report of 41 cases. Transplantation 1999;68:1717-1721.
21. Buell JF, Trofe J, Hanaway MJ, et al. Immunosuppression and Merkel cell cancer. Transplant Proc. 2002;34:1780-1781.
22. Friedlaender MM, Rubinger D, Rosenbaum E, Amir G, Siguencia E. Temporary regression of Merkel cell carcinoma metastases after cessation of cyclosporine. Transplantation 2002;73:1849-1850.
23. Feng H, Shuda M, Chang Y, Moore PS. Clonal integration of a polyomavirus in human Merkel cell carcinoma. Science 2008;319:1096-1100.
24. Shuda M, Arora R, Kwun HJ, et al. Human Merkel cell polyomavirus infection I. MCV T antigen expression in Merkel cell carcinoma, lymphoid tissues and lymphoid tumors. Int J Cancer 2009;125:1243-1249.
25. Lemos BD, Storer BE, Iyer JG, et al. Pathologic nodal evaluation improves prognostic accuracy in Merkel cell carcinoma: Analysis of 5823 cases as the basis of the first consensus staging system. J Am Acad Dermatol. 2010;63:751-761.
26. Smith PD, Patterson JW. Merkel cell carcinoma (neuroendocrine carcinoma of the skin). Am J Clin Pathol. 2001;115(Suppl):S68-S78.
27. Bobos M, Hytiroglou P, Kostopoulos I, Karkavelas G, Papadimitriou CS. Immunohistochemical distinction between merkel cell carcinoma and small cell carcinoma of the lung. Am J Dermatopathol. 2006;28:99-104.
28. Bichakjian CK, Lowe L, Lao CD, et al. Merkel cell carcinoma: Critical review with guidelines for multidisciplinary management. Cancer 2007;110:1-12.
29. Yiengpruksawan A, Coit DG, Thaler HT, Urmacher C, Knapper WK. Merkel cell carcinoma: Prognosis and management. Arch Surg. 1991;126:1514-1519.
30. Boyle F, Pendlebury S, Bell D. Further insights into the natural history and management of primary cutaneous neuroendocrine (Merkel cell) carcinoma. Int J Radiat Oncol Biol Phys. 1995;31:315-323.
31. Medina-Franco H, Urist MM, Fiveash J, et al. Multimodality treatment of Merkel cell carcinoma: Case series and literature review of 1024 cases. Ann Surg Oncol. 2001;8:204-208.
32. Allen PJ, Bowne WB, Jaques DP, Brennan MF, Busam K, Coit DG. Merkel cell carcinoma: Prognosis and treatment of patients from a single institution. J Clin Oncol. 2005;23:2300-2309.
33. Kokoska ER, Kokoska MS, Collins BT, Stapleton DR, Wade TP. Early aggressive treatment for Merkel cell carcinoma improves outcome. Am J Surg. 1997;174:688-693.
34. Gupta SG, Wang LC, Peñas PF, Gellenthin M, Lee SJ, Nghiem P. Sentinel lymph node biopsy for evaluation and treatment of patients with Merkel cell carcinoma: The Dana-Farber experience and meta-analysis of the literature. Arch Dermatol. 2006;142:685-690.
35. Fields RC, Strong VE, Gönen M, et al. Recurrence and survival after pathologic complete response to preoperative therapy followed by surgery for gastric or gastrooesophageal adenocarcinoma. Br J Cancer 2011;104:1840-1847.
36. Belhocine T, Pierard GE, Frühling J, et al. Clinical addedvalue of 18FDG PET in neuroendocrine-merkel cell carcinoma. Oncol Rep. 2006;16:347-352.
37. Concannon R, Larcos GS, Veness M. The impact of (18) F-FDG PET-CT scanning for staging and management of Merkel cell carcinoma: Results from Westmead Hospital, Sydney, Australia. J Am Acad Dermatol. 2010;62:76-84.
38. Zager JS, Brodsky S, Berman CG. Imaging of Merkel cell carcinoma. Curr Probl Cancer 2010;34:65-76.
39. Edge SB, Byrd DR, Compton CC, et al. AJCC Cancer Staging Manual. Vol. 1, 7th ed. New York: Springer; 2010.
40. Mehrany K, Otley CC, Weenig RH, Phillips PK, Roenigk RK, Nguyen TH. A meta-analysis of the prognostic significance of sentinel lymph node status in Merkel cell carcinoma. Dermatol Surg. 2002;28:113-117; discussion 117.
41. Gillenwater AM, Hessel AC, Morrison WH, et al. Merkel cell carcinoma of the head and neck: Effect of surgical excision and radiation on recurrence and survival. Arch Otolaryngol Head Neck Surg. 2001;127:149-154.
42. Merkel cell carcinoma. In: National Comprehensive Cancer Network, ed. NCCN Guidelines. Vol. 1: Fort Washington, Pa: National Comprehensive Cancer Network; 2012.
43. O'Connor WJ, Roenigk RK, Brodland DG. Merkel cell carcinoma: Comparison of Mohs micrographic surgery and wide excision in eighty-six patients. Dermatol Surg. 1997;23:929-933.
44. Boyer JD, Zitelli JA, Brodland DG, et al. Local control of primary Merkel cell carcinoma: Review of 45 cases treated with Mohs micrographic surgery with and without adjuvant radiation. J Am Acad Dermatol. 2002;47:885-892.
45. Veness MJ, Perera L, McCourt J, et al. Merkel cell carcinoma: Improved outcome with adjuvant radiotherapy. ANZ J Surg. 2005;75:275-281.
46. Morton DL, Thompson JF, Cochran AJ, et al.; MSLT Group. Sentinel-node biopsy or nodal observation in melanoma. N Engl J Med. 2006;355:1307-1317.
47. Veness M, Foote M, Gebski V, Poulsen M. The role of radiotherapy alone in patients with merkel cell carcinoma: Reporting the Australian experience of 43 patients. Int J Radiat Oncol Biol Phys. 2010;78:703-709.
48. Lewis KG, Weinstock MA, Weaver AL, Otley CC. Adjuvant local irradiation for Merkel cell carcinoma. Arch Dermatol. 2006;142:693-700.
49. Mojica P, Smith D, Ellenhorn JD. Adjuvant radiation therapy is associated with improved survival in Merkel cell carcinoma of the skin. J Clin Oncol. 2007;25:1043-1047.
50. Poulsen M, Rischin D, Walpole E, et al.; Trans-Tasman Radiation Oncology Group. High-risk Merkel cell carcinoma of the skin treated with synchronous carboplatin/etoposide and radiation: A Trans-Tasman Radiation Oncology Group Study-TROG 96:07. J Clin Oncol. 2003;21:4371-4376.
51. Poon D, Yap SP, Mancer K, Quek ST, Soh LT. Induction chemotherapy followed by radiotherapy in Merkel-cell carcinoma. Lancet Oncol. 2004;5:509-510.
52. Voog E, Biron P, Martin JP, Blay JY. Chemotherapy for patients with locally advanced or metastatic Merkel cell carcinoma. Cancer 1999;85:2589-2595.
53. Tai PT, Yu E, Winquist E, et al. Chemotherapy in neuroendocrine/Merkel cell carcinoma of the skin: Case series and review of 204 cases. J Clin Oncol. 2000;18:2493-2499.
54. Ott MJ, Tanabe KK, Gadd MA, et al. Multimodality management of Merkel cell carcinoma. Arch Surg. 1999;134:388-392; discussion 392.
55. Rockville Merkel Cell Carcinoma Group. Merkel cell carcinoma: Recent progress and current priorities on etiology, pathogenesis, and clinical management. J Clin Oncol. 2009;27:4021-4026.
56. Akhtar S, Oza KK, Wright J. Merkel cell carcinoma: Report of 10 cases and review of the literature. J Am Acad Dermatol. 2000;43(5 Pt 1):755-767.